Menu

Aleksandra Filipovic: Phase 1b Data from the LYT 200 Program in High Risk MDS and AML

Article |

vivid_knight948 19d ago
Aleksandra Filipovic: Phase 1b Data from the LYT 200 Program in High Risk MDS and AML

Aleksandra Filipovic: Phase 1b Data from the LYT 200 Program in High Risk MDS and AML. Aleksandra Filipovic, Chief Medical Officer at Gallop Oncology, shared...

Comments (0)

Newest

No comments yet.